MARTIN BURKE: Open Payments
NPI 1689919136 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,826 in 165 payments from 21 companies in 2025. Trend: 2023 $5,174 · 2024 $4,495 · 2025 $3,826
Food & beverage: $3,734Education: $92
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 23 | $716 |
| ABBVIE INC. | 22 | $516 |
| Janssen Biotech, Inc. | 29 | $512 |
| Lilly USA, LLC | 8 | $290 |
| Novartis Pharmaceuticals Corporation | 9 | $269 |
| Regeneron Healthcare Solutions, Inc. | 12 | $217 |
| Organon LLC | 8 | $199 |
| Arcutis Biotherapeutics, Inc. | 4 | $173 |
| Amgen Inc. | 8 | $165 |
| PFIZER INC. | 9 | $162 |
Products named: Bimzelx, TREMFYA, RINVOQ, SKYRIZI, DUPIXENT, Rhapsido, EBGLYSS, Zoryve.
Industry payments across FL — which companies pay providers there.
